GENE ONLINE|News &
Opinion
Blog

Ruchi Jhonsa

WRITTEN BY Ruchi Jhonsa

CRISPR-Based Analgesics Aspire to Mitigate Opioid Crisis
2021-03-16
Vir, GSK’s Antibody Therapy Effective Against COVID-19 Variants, Reduces Hospitalization and Deaths by 85%
2021-03-11
After Cardiovascular Disease, Novartis’ Rare Disease Drug Flops in Late-Stage Lung Cancer Study
2021-03-09
Perrigo Splits Businesses, Offloads Generic Division to Private Equity
2021-03-04
BridgeBio Bags First FDA Nod with Rare Disease Drug Acquired from Alexion
2021-03-03
Merck Acts on its Post-Keytruda Plan, Spends $1.85B to Acquire Pandion for Autoimmune Therapies
2021-02-26
AstraZeneca Voluntarily Withdraws Checkpoint Inhibitor Approved for Bladder Cancer Indication
2021-02-25
Beam Therapeutics Acquires Georgia Tech Spin Out, Seeks Non-Viral Gene Therapy Delivery Vehicles
2021-02-25
Lilly to Expand Foothold in the Billion-Dollar Autoimmune and Inflammatory Disease Market with this New Collaboration
2021-02-20
BIOCEO21: Scientists and Investors Weigh on Pioneering Innovations and Investments in Oncology
2021-02-18
G1 Therapeutics’ Drug Reduces Chemo Related Side Effects, Nabs FDA OK
2021-02-16
Ensoma Enters Gene-Editing Market with $70 Million Funding and Takeda Partnership
2021-02-12
AbbVie Signs Off-the-Shelf CAR-T Therapy Pact with Jennifer Doudna’s Caribou Biosciences
2021-02-11
TG Therapeutics Gets Conditional FDA Okay for its First Lymphoma Drug
2021-02-09
Sana Biotechnology Makes Wall Street Debut with $587.5 Million IPO
2021-02-05
1 2 3 4 … 13
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top